In my last few posts I shared ideas on how to enhance product planning efforts to maximize the market potential for a product. This is just one important component. A truly successful approach to product development requires a solid understanding of the clinical issues and data, a careful assessment of the market, and a framework
Details

The primary care shortage in the US is destined to grow even more dire as indicated in an article featured in February 12th issue of the Washington Post. In light of the Healthcare Affordability Act there will be a need for at least 30,000 more primary care providers given the fact that tens of millions more individuals will likely enter the
Details

The life sciences industry is certainly experiencing stormy seas. However, today, the industry can celebrate a victory in the battle for innovation. Biogen’s approved label change for Tysabri will make it easier for physicians to identify patients at highest and lowest risk of developing progressive multifocal leukoencephalopathy (PML), a deadly brain infection linked to the drug. It’s
Details

The life science industry is facing tremendous challenges, and you don’t need to face them alone. There are numerous management consulting firms that will help you tackle your most pressing challenges. Management consulting firms can provide deep insights and analytical abilities, unique processes for overcoming challenges, and needed resources to solve pressing business issues. Hiring
Details

I’m a strong proponent of partnerships with life science companies and research institutions. I’m motivated by the inherent synergies of these partnerships, and the opportunities they represent to expedite drug development cycles and lengthen the amount of patent exclusivity once on the market. The main objective of these partnerships is to spur innovation and ultimately
Details

In previous blog posts I made a strong point to look at research institutions as potential partners for product development and encouraged life science companies to “cast a wide net” when evaluating potential partners. Just as important to “casting a wide net” is refining the information once institutions are identified to develop a list of potential partners
Details

Through clinical data gap analysis, a company can determine if it is truly necessary to follow the common paths being taken by the competition, jump on the next important clinical use, and uncover very useful data that already exists and can be instrumental to further product growth. This paper provides insights based on years of
Details

I am excited about the significant opportunities life science companies and research institutions have to work together to commercialize new molecules and treatments. Forming these strategic partnerships is a critical undertaking, and much time and money can be wasted if it’s not done well. I want to share with you the essential elements for identifying
Details

We are all aware of the tremendous challenges the life science industry is facing. This industry is at a critical juncture and we need to do things differently if we want to survive. I’m passionate about the life sciences and I see many opportunities. I’m all about innovation and doing things differently because we have
Details